COMP <GO>
EFX vs BAC // FREE CASH FLOW YIELD
Equifax Inc. (NYSE) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: EFX 9
— BAC 5
▲ FREE CASH FLOW YIELD LEADER: EFX
LAST: $184.60 (+2.90%) • MKT CAP: $20.99B
fcf-yield
6.39%
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
fcf-yield
2.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EFX VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EFX | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.20% | 2.50% | +7.70 | EFX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.7x | 30.2x | -11.50 | EFX | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 6.39% | 2.10% | +4.29 | EFX | /fcf-yield <GO> |
| Operating Margin | 18.00% | 32.90% | -14.90 | BAC | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 27.00% | -16.10 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 6.90% | 6.80% | +0.10 | EFX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.11% | 0.00% | +1.11 | EFX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.25 | 0.45 | +2.80 | EFX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | EFX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.60% | +0.70 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.5 | 27.7 | +39.79 | EFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.90 | +0.21 | EFX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.6x | 10.9x | +18.70 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.99B | $357.61B | -$336.62B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EFX REV | BAC REV | EFX GROSS % | BAC GROSS % | EFX FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.07B | $113.10B | 44.0% | 44.0% | $1.34B | $7.52B |
| FY 2024 | $5.68B | $105.86B | 44.0% | 44.0% | $1.07B | -$13.57B |
| FY 2023 | $5.27B | $102.77B | 44.0% | 44.0% | $879.9M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EFX // BETA 1.11
BAC // BETA 0.90